{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:35:52Z","timestamp":1793583352544,"version":"4.5.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"am","delay-in-days":199,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.pharmthera.2022.108198","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T21:03:37Z","timestamp":1651698217000},"page":"108198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Clinical implications of tristetraprolin (TTP) modulation in the treatment of inflammatory diseases"],"prefix":"10.1016","volume":"239","author":[{"given":"Brittany L.","family":"Snyder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry J.","family":"Blackshear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2022.108198_bb0005","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1002\/jcp.27860","article-title":"Strategies toward rheumatoid arthritis therapy; the old and the new","volume":"234","author":"Abbasi","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0010","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nprot.2009.120","article-title":"Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications","volume":"4","author":"Abel","year":"2009","journal-title":"Nature Protocols"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0015","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92979","article-title":"Tristetraprolin expression by keratinocytes controls local and systemic inflammation","volume":"2","author":"Andrianne","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0020","article-title":"Tristetraprolin expression by keratinocytes protects against skin carcinogenesis. JCI","volume":"6","author":"Assabban","year":"2021","journal-title":"Insight"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0025","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.berh.2019.02.003","article-title":"Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents","volume":"32","author":"Atzeni","year":"2018","journal-title":"Best Practice & Research. Clinical Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0030","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.1182\/blood-2011-07-347237","article-title":"AU-rich RNA binding proteins in hematopoiesis and leukemogenesis","volume":"118","author":"Baou","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0035","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.ajo.2005.07.017","article-title":"Vitrectomy in the treatment of uveitis","volume":"140","author":"Becker","year":"2005","journal-title":"American Journal of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1095\/biolreprod.105.040527","article-title":"Zfp36l3, a rodent X chromosome gene encoding a placenta-specific member of the Tristetraprolin family of CCCH tandem zinc finger proteins","volume":"73","author":"Blackshear","year":"2005","journal-title":"Biology of Reproduction"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0045","first-page":"E5863","article-title":"Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II\/III spinal muscular atrophy","volume":"112","author":"Bogdanik","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0050","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbagrm.2013.02.003","article-title":"Tristetraprolin (TTP): Interactions with mRNA and proteins, and current thoughts on mechanisms of action","volume":"1829","author":"Brooks","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0055","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jmb.2017.12.018","article-title":"Tryptophan-mediated interactions between Tristetraprolin and the CNOT9 subunit are required for CCR4-NOT Deadenylase complex recruitment","volume":"430","author":"Bulbrook","year":"2018","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0060","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jcmgh.2021.07.015","article-title":"Tristetraprolin prevents gastric metaplasia in mice by suppressing pathogenic inflammation","volume":"12","author":"Busada","year":"2021","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2021.07.015","article-title":"Tristetraprolin prevents gastric metaplasia in mice by suppressing pathogenic inflammation","author":"Busada","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"637\u2013652","key":"10.1016\/j.pharmthera.2022.108198_bb0070","article-title":"Glucocorticoids and androgens protect from gastric metaplasia by suppressing group 2 innate lymphoid cell activation","volume":"161","author":"Busada","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0075","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI123233","article-title":"Endogenous glucocorticoids prevent gastric metaplasia by suppressing spontaneous inflammation","volume":"129","author":"Busada","year":"2019","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5858\/arpa.2015-0519-RA","article-title":"Acute lung injury: A clinical and molecular review","volume":"140","author":"Butt","year":"2016","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0085","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1586\/14789450.4.6.711","article-title":"Phosphorylation site analysis of the anti-inflammatory and mRNA-destabilizing protein tristetraprolin","volume":"4","author":"Cao","year":"2007","journal-title":"Expert Review of Proteomics"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0090","article-title":"Identification of a major phosphopeptide in human tristetraprolin by phosphopeptide mapping and mass spectrometry","volume":"9","author":"Cao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/BJ20051316","article-title":"Identification of the anti-inflammatory protein tristetraprolin as a hyperphosphorylated protein by mass spectrometry and site-directed mutagenesis","volume":"394","author":"Cao","year":"2006","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0100","doi-asserted-by":"crossref","first-page":"21489","DOI":"10.1074\/jbc.M400900200","article-title":"Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein","volume":"279","author":"Cao","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0105","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0300985815588612","article-title":"Mouse models of rheumatoid arthritis","volume":"52","author":"Caplazi","year":"2015","journal-title":"Veterinary Pathology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0110","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1182\/blood.V98.8.2389","article-title":"Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome","volume":"98","author":"Carballo","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0115","doi-asserted-by":"crossref","first-page":"42580","DOI":"10.1074\/jbc.M104953200","article-title":"Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway","volume":"276","author":"Carballo","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0120","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1172\/JCI119649","article-title":"Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (\u2212\/\u2212) mice. Evidence that monocyte\/macrophage progenitors may be responsible for TNFalpha overproduction","volume":"100","author":"Carballo","year":"1997","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0125","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.281.5379.1001","article-title":"Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin","volume":"281","author":"Carballo","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0130","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood.V95.6.1891","article-title":"Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability","volume":"95","author":"Carballo","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaut.2006.01.004","article-title":"Genetic variations in ZFP36 and their possible relationship to autoimmune diseases","volume":"26","author":"Carrick","year":"2006","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0140","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0145","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.140.5.1490","article-title":"A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens","volume":"140","author":"Caspi","year":"1988","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0150","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1084\/jem.20101355","article-title":"IL-1R-MyD88 signaling in keratinocyte transformation and carcinogenesis","volume":"209","author":"Cataisson","year":"2012","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0155","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm.3897","article-title":"Heterogeneity of autoimmune diseases: Pathophysiologic insights from genetics and implications for new therapies","volume":"21","author":"Cho","year":"2015","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0160","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3389\/fimmu.2020.02164","article-title":"Tristetraprolin overexpression in non-hematopoietic cells protects against acute lung injury in mice","volume":"11","author":"Choudhary","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0165","doi-asserted-by":"crossref","first-page":"10176","DOI":"10.1074\/jbc.M310486200","article-title":"MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding","volume":"279","author":"Chrestensen","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0170","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1042\/BST20160166","article-title":"The control of inflammation via the phosphorylation and dephosphorylation of tristetraprolin: A tale of two phosphatases","volume":"44","author":"Clark","year":"2016","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0175","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/wrna.1332","article-title":"The Ccr4-not complex is a key regulator of eukaryotic gene expression","volume":"7","author":"Collart","year":"2016","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrgastro.2015.135","article-title":"Biologic agents for IBD: Practical insights","volume":"12","author":"Danese","year":"2015","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0185","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.4049\/jimmunol.180.4.2545","article-title":"Tristetraprolin regulates CXCL1 (KC) mRNA stability","volume":"180","author":"Datta","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0190","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41435-019-0057-0","article-title":"The many faces of tumor necrosis factor signaling in the intestinal epithelium","volume":"20","author":"Delgado","year":"2019","journal-title":"Genes and Immunity"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0195","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1042\/BST20120074","article-title":"Deadenylation of cytoplasmic mRNA by the mammalian Ccr4-not complex","volume":"40","author":"Doidge","year":"2012","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0200","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"The British Journal of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1902\/jop.2015.140520","article-title":"Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012","volume":"86","author":"Eke","year":"2015","journal-title":"Journal of Periodontology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0210","doi-asserted-by":"crossref","first-page":"14413","DOI":"10.1038\/s41598-019-50957-9","article-title":"Tristetraprolin targets Nos2 expression in the colonic epithelium","volume":"9","author":"Eshelman","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0215","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nsmb.2572","article-title":"Structural basis for the recruitment of the human CCR4-NOT deadenylase complex by tristetraprolin","volume":"20","author":"Fabian","year":"2013","journal-title":"Nature Structural & Molecular Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0220","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0225","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis","volume":"43","author":"Flutter","year":"2013","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0230","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1074\/jbc.M801234200","article-title":"A unique C-terminal repeat domain maintains the cytosolic localization of the placenta-specific tristetraprolin family member ZFP36L3","volume":"283","author":"Frederick","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0235","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nri.2016.129","article-title":"RNA-binding proteins in immune regulation: A focus on CCCH zinc finger proteins","volume":"17","author":"Fu","year":"2017","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0240","first-page":"309","article-title":"The coupled and uncoupled mechanisms by which trans-acting factors regulate mRNA stability and translation","volume":"161","author":"Fukao","year":"2017","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0245","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1515\/hsz-2013-0197","article-title":"What goes up must come down: Molecular basis of MAPKAP kinase 2\/3-dependent regulation of the inflammatory response and its inhibition","volume":"394","author":"Gaestel","year":"2013","journal-title":"Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0250","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/embor.2009.9","article-title":"miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis","volume":"10","author":"Gebeshuber","year":"2009","journal-title":"EMBO Reports"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0255","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrg3813","article-title":"A census of human RNA-binding proteins","volume":"15","author":"Gerstberger","year":"2014","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0260","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ympev.2015.10.016","article-title":"Emergence and evolution of Zfp36l3","volume":"94","author":"Gingerich","year":"2016","journal-title":"Molecular Phylogenetics and Evolution"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0265","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0270","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1128\/MCB.26.6.2399-2407.2006","article-title":"Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine\/uridine-rich element","volume":"26","author":"Hitti","year":"2006","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0275","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1699-0463.1989.tb00446.x","article-title":"Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity","volume":"97","author":"Holmdahl","year":"1989","journal-title":"APMIS"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0280","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nsmb738","article-title":"Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d","volume":"11","author":"Hudson","year":"2004","journal-title":"Nature Structural & Molecular Biology"},{"issue":"21\u201324","key":"10.1016\/j.pharmthera.2022.108198_bb0285","article-title":"Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach","volume":"142","author":"Huh","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0290","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00296-017-3726-1","article-title":"Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014","volume":"37","author":"Hunter","year":"2017","journal-title":"Rheumatology International"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0295","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13073-017-0450-0","article-title":"Advances in the delivery of RNA therapeutics: From concept to clinical reality","volume":"9","author":"Kaczmarek","year":"2017","journal-title":"Genome Medicine"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0300","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.4049\/jimmunol.1101149","article-title":"Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation","volume":"187","author":"Kang","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0305","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.4049\/jimmunol.1002806","article-title":"Deletion of tristetraprolin caused spontaneous reactive granulopoiesis by a non-cell-autonomous mechanism without disturbing long-term hematopoietic stem cell quiescence","volume":"186","author":"Kaplan","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0310","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1074\/jbc.M111.312652","article-title":"Direct binding of specific AUF1 isoforms to tandem zinc finger domains of tristetraprolin (TTP) family proteins","volume":"287","author":"Kedar","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0315","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/nprot.2006.393","article-title":"Collagen antibody-induced arthritis","volume":"1","author":"Khachigian","year":"2006","journal-title":"Nature Protocols"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0320","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","article-title":"Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies","volume":"10","author":"Kontoyiannis","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cyto.2015.11.007","article-title":"Posttranscriptional regulation of cytokine expression","volume":"89","author":"Kovarik","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0330","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/msb.2011.93","article-title":"Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation","volume":"7","author":"Kratochvill","year":"2011","journal-title":"Molecular Systems Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0335","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41385-020-0302-x","article-title":"The RNA-binding protein tristetraprolin regulates RALDH2 expression by intestinal dendritic cells and controls local Treg homeostasis","volume":"14","author":"La","year":"2021","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0340","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1128\/MCB.19.6.4311","article-title":"Evidence that Tristetraprolin binds to AU-rich elements and promotes the Deadenylation and destabilization of tumor necrosis factor alpha mRNA","volume":"19","author":"Lai","year":"1999","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0345","doi-asserted-by":"crossref","first-page":"9606","DOI":"10.1074\/jbc.M110395200","article-title":"Interactions of CCCH zinc finger proteins with mRNA: Non-binding tristetraprolin mutants exert an inhibitory effect on degradation of AU-rich element-containing mRNAs","volume":"277","author":"Lai","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0350","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1128\/MCB.23.11.3798-3812.2003","article-title":"Tristetraprolin and its family members can promote the cell-free Deadenylation of AU-rich element-containing mRNAs by poly(a) ribonuclease","volume":"23","author":"Lai","year":"2003","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0355","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1128\/MCB.00945-06","article-title":"Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts","volume":"26","author":"Lai","year":"2006","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0360","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1074\/jbc.M113.466326","article-title":"Mutational and structural analysis of the tandem zinc finger domain of tristetraprolin","volume":"289","author":"Lai","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0365","doi-asserted-by":"crossref","first-page":"16556","DOI":"10.1016\/S0021-9258(17)46259-4","article-title":"Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein","volume":"265","author":"Lai","year":"1990","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0370","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00488-17","article-title":"A Knock-in Tristetraprolin (TTP) zinc finger point mutation in mice: Comparison with complete TTP deficiency","volume":"38","author":"Lai","year":"2018","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0375","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00029-19","article-title":"Importance of the conserved carboxyl-terminal CNOT1 binding domain to Tristetraprolin activity in vivo","volume":"39","author":"Lai","year":"2019","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0380","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1531","article-title":"The tandem zinc finger RNA binding domain of members of the tristetraprolin protein family","volume":"10","author":"Lai","year":"2019","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0385","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1073\/pnas.0404328101","article-title":"Critical role for granulocyte colony-stimulating factor in inflammatory arthritis","volume":"101","author":"Lawlor","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0390","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.febslet.2011.11.021","article-title":"Tristetraprolin down-regulates IL-17 through mRNA destabilization","volume":"586","author":"Lee","year":"2012","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0395","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nbt.3589","article-title":"Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames","volume":"34","author":"Liang","year":"2016","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0400","article-title":"Update on the Pathomechanism, diagnosis, and treatment options for rheumatoid arthritis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0405","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: Conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0410","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1101\/gad.1282305","article-title":"Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1","volume":"19","author":"Lykke-Andersen","year":"2005","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0415","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1128\/MCB.21.9.6461-6469.2001","article-title":"Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability","volume":"21","author":"Mahtani","year":"2001","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.711633","article-title":"Post-transcriptional regulation of immune responses and inflammatory diseases by RNA-binding ZFP36 family proteins","volume":"12","author":"Makita","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0425","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","article-title":"Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9","volume":"15","author":"Mandal","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0430","doi-asserted-by":"crossref","first-page":"27590","DOI":"10.1074\/jbc.M110.136473","article-title":"MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment","volume":"285","author":"Marchese","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0435","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1167\/iovs.15-17280","article-title":"Characterization of a new epitope of IRBP that induces moderate to severe Uveoretinitis in mice with H-2b haplotype","volume":"56","author":"Mattapallil","year":"2015","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0440","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-011110-130158","article-title":"The acute respiratory distress syndrome: Pathogenesis and treatment","volume":"6","author":"Matthay","year":"2011","journal-title":"Annual Review of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0445","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1501s77","article-title":"Experimental autoimmune encephalomyelitis in the mouse","author":"Miller","year":"2007","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0450","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.20120707","article-title":"Tristetraprolin regulation of interleukin 23 mRNA stability prevents a spontaneous inflammatory disease","volume":"210","author":"Molle","year":"2013","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0455","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jid.2019.01.006","article-title":"Imiquimod-induced psoriasis in mice depends on the IL-17 signaling of keratinocytes","volume":"139","author":"Moos","year":"2019","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0460","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.2011.0065","article-title":"Cytokines in autoimmunity: Role in induction, regulation, and treatment","volume":"31","author":"Moudgil","year":"2011","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0465","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/archopht.122.6.845","article-title":"Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis","volume":"122","author":"Murphy","year":"2004","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0470","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1084","article-title":"Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease","volume":"8","author":"Nair","year":"2019","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0480","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/1744666X.2017.1295850","article-title":"The role and therapeutic targeting of IL-6 in rheumatoid arthritis","volume":"13","author":"Narazaki","year":"2017","journal-title":"Expert Review of Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0485","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"International Ophthalmology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0490","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1006\/jaut.1996.0077","article-title":"Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease","volume":"9","author":"Nussenblatt","year":"1996","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0495","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/14397595.2018.1546357","article-title":"IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review","volume":"29","author":"Ogata","year":"2019","journal-title":"Modern Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0500","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/path.5214","article-title":"Interferon-gamma directly induces gastric epithelial cell death and is required for progression to metaplasia","volume":"247","author":"Osaki","year":"2019","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0505","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.1158\/0008-5472.CAN-05-1936","article-title":"Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2\/microsomal prostaglandin E synthase-1 transgenic mice","volume":"65","author":"Oshima","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0510","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.iac.2017.01.012","article-title":"Adverse reactions to biologic therapy","volume":"37","author":"Patel","year":"2017","journal-title":"Immunology and Allergy Clinics of North America"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0515","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1073\/pnas.1519906113","article-title":"Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies","volume":"113","author":"Patial","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0520","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcmgh.2016.11.001","article-title":"Murine models of gastric Corpus Preneoplasia","volume":"3","author":"Petersen","year":"2017","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"issue":"1727\u20131738","key":"10.1016\/j.pharmthera.2022.108198_bb0525","article-title":"Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells","volume":"146","author":"Petersen","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0530","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00018-014-1762-5","article-title":"Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling","volume":"72","author":"Plociennikowska","year":"2015","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0535","doi-asserted-by":"crossref","first-page":"L973","DOI":"10.1152\/ajplung.00219.2014","article-title":"Temporal regulation of cytokine mRNA expression by tristetraprolin: Dynamic control by p38 MAPK and MKP-1","volume":"308","author":"Prabhala","year":"2015","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0540","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1289\/ehp.1408626","article-title":"Global analysis of posttranscriptional gene expression in response to sodium arsenite","volume":"123","author":"Qiu","year":"2015","journal-title":"Environmental Health Perspectives"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0545","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1189\/jlb.3A0214-106R","article-title":"Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuli","volume":"97","author":"Qiu","year":"2015","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0550","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.4049\/jimmunol.1103700","article-title":"Myeloid-specific tristetraprolin deficiency in mice results in extreme lipopolysaccharide sensitivity in an otherwise minimal phenotype","volume":"188","author":"Qiu","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0555","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cellsig.2016.01.009","article-title":"Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells","volume":"28","author":"Rahman","year":"2016","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0560","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1038\/s41467-019-11094-z","article-title":"Reconstitution of recombinant human CCR4-NOT reveals molecular insights into regulated deadenylation","volume":"10","author":"Raisch","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109868","article-title":"Cataloguing the phosphorylation sites of tristetraprolin (TTP): Functional implications for inflammatory diseases","volume":"78","author":"Rezcallah","year":"2021","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0570","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.4049\/jimmunol.156.4.1654","article-title":"Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10.A mice","volume":"156","author":"Rizzo","year":"1996","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0575","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4049\/jimmunol.1801221","article-title":"The role of TTP phosphorylation in the regulation of inflammatory cytokine production by MK2\/3","volume":"203","author":"Ronkina","year":"2019","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0580","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4049\/jimmunol.1402826","article-title":"Dominant suppression of inflammation via targeted mutation of the mRNA destabilizing protein Tristetraprolin","volume":"195","author":"Ross","year":"2015","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0585","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cell.2012.06.033","article-title":"Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state","volume":"150","author":"Rounbehler","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102398","article-title":"Failure of anti-TNF treatment in patients with rheumatoid arthritis: The pros and cons of the early use of alternative biological agents","volume":"18","author":"Rubbert-Roth","year":"2019","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0595","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-1-4939-3603-8_28","article-title":"Modeling murine gastric metaplasia through tamoxifen-induced acute parietal cell loss","volume":"1422","author":"Saenz","year":"2016","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0600","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1093\/nar\/gkr011","article-title":"Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin","volume":"39","author":"Sandler","year":"2011","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0605","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1042\/BST0360491","article-title":"Control of mRNA decay by phosphorylation of tristetraprolin","volume":"36","author":"Sandler","year":"2008","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0610","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/wrna.28","article-title":"The roles of TTP and BRF proteins in regulated mRNA decay","volume":"2","author":"Sanduja","year":"2011","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0615","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nrrheum.2013.4","article-title":"Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis","volume":"9","author":"van Schouwenburg","year":"2013","journal-title":"Nature Reviews Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0620","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA: a Cancer Journal for Clinicians"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0625","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.71","article-title":"IL-23- and Imiquimod-induced models of experimental psoriasis in mice","volume":"125","author":"Singh","year":"2019","journal-title":"Current Protocols in Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0630","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2009.12.044","article-title":"Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter","volume":"138","author":"Sohn","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0635","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/rheumatology\/33.9.798","article-title":"Collagen arthritis\u2014what can it teach us?","volume":"33","author":"Staines","year":"1994","journal-title":"British Journal of Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0640","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0022034518756889","article-title":"Tristetraprolin is required for alveolar bone homeostasis","volume":"97","author":"Steinkamp","year":"2018","journal-title":"Journal of Dental Research"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0645","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm.2625","article-title":"Optimization of current and future therapy for autoimmune diseases","volume":"18","author":"Steinman","year":"2012","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0650","doi-asserted-by":"crossref","first-page":"11689","DOI":"10.1074\/jbc.M709657200","article-title":"Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin","volume":"283","author":"Stoecklin","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0655","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2009-04-214619","article-title":"Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis","volume":"114","author":"Stumpo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0660","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1128\/MCB.24.14.6445-6455.2004","article-title":"Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family","volume":"24","author":"Stumpo","year":"2004","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0665","first-page":"1424","article-title":"Deficiency of the placenta- and yolk sac-specific tristetraprolin family member ZFP36L3 identifies likely mRNA targets and an unexpected link to placental iron metabolism","volume":"143","author":"Stumpo","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0670","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1158\/0008-5472.CAN-07-2751","article-title":"Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells","volume":"68","author":"Suswam","year":"2008","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0675","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/s10165-008-0085-5","article-title":"Tristetraprolin (TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals","volume":"18","author":"Suzuki","year":"2008","journal-title":"Modern Rheumatology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0680","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.ajpath.2012.08.017","article-title":"Transgenic expression of interferon-gamma in mouse stomach leads to inflammation, metaplasia, and dysplasia","volume":"181","author":"Syu","year":"2012","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0685","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1074-7613(00)80411-2","article-title":"A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency","volume":"4","author":"Taylor","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0690","doi-asserted-by":"crossref","first-page":"13341","DOI":"10.1074\/jbc.270.22.13341","article-title":"Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro","volume":"270","author":"Taylor","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0695","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4049\/jimmunol.178.1.463","article-title":"Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages","volume":"178","author":"Thorley","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0700","first-page":"7418","article-title":"The RNA-binding protein TTP is a global post-transcriptional regulator of feedback control in inflammation","volume":"44","author":"Tiedje","year":"2016","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0705","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/s1677-5538.ibju.2015.0436","article-title":"Robot - assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor","volume":"43","author":"Torricelli","year":"2017","journal-title":"International Braz J Urol"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0710","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ccr.2008.10.011","article-title":"Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice","volume":"14","author":"Tu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0715","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1074\/mcp.M112.017020","article-title":"Affinity capture and identification of host cell factors associated with hepatitis C virus (+) strand subgenomic RNA","volume":"12","author":"Upadhyay","year":"2013","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0720","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"Journal of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0725","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.40670","article-title":"RNA-binding proteins distinguish between similar sequence motifs to promote targeted deadenylation by Ccr4-not","volume":"8","author":"Webster","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0730","doi-asserted-by":"crossref","first-page":"24413","DOI":"10.1074\/jbc.M115.673012","article-title":"Functional equivalence of an evolutionarily conserved RNA binding module","volume":"290","author":"Wells","year":"2015","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0735","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tibs.2016.12.003","article-title":"An ancient family of RNA-binding proteins: Still important!","volume":"42","author":"Wells","year":"2017","journal-title":"Trends in Biochemical Sciences"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0740","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/mmi.12913","article-title":"Post-transcriptional regulation of transcript abundance by a conserved member of the tristetraprolin family in Candida albicans","volume":"95","author":"Wells","year":"2015","journal-title":"Molecular Microbiology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0745","article-title":"Regulated Tristetraprolin overexpression dampens the development and pathogenesis of experimental autoimmune uveitis","volume":"11","author":"Xu","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0750","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pharmthera.2013.09.004","article-title":"Targeting interleukin-6 in inflammatory autoimmune diseases and cancers","volume":"141","author":"Yao","year":"2014","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108198_bb0755","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/jir.2010.0154","article-title":"Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3\u2032 untranslated region","volume":"31","author":"Zhao","year":"2011","journal-title":"Journal of Interferon & Cytokine Research"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:26:35Z","timestamp":1759011995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725822000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":151,"alternative-id":["S0163725822000924"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108198","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical implications of tristetraprolin (TTP) modulation in the treatment of inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108198"}}